Multiple organ dysfunction syndrome and death secondary to Cyberlindnera fabianii

Polonelli, 2000, The efficacy of acquired humoral and celular immunity in the prevention and therapy of experimental fungal infections, Med. Mycol., 38, 281, 10.1080/mmy.38.1.281.292 Netea, 2015, Immune defense against Candida fungal infections, Nat. Rev. Immunol., 15, 630, 10.1038/nri3897 2016 Freel, 2014, Genome sequence of the yeast Cyberlindnera fabianii (hansenula fabianii), Genome Announc., 2, 1, 10.1128/genomeA.00638-14 Katagiri, 2016, Fatal Cyberlindnera fabianii fungemia in a patient with mixed phenotype acute leukemia after umbilical cord blood transplantation, Int. J. Hematol., 103, 592, 10.1007/s12185-016-1953-y Hof, 2017, Peritonitis in a neonate due to Cyberlindnera fabianii, an ascomycetic yeast, Infection, 45, 921, 10.1007/s15010-017-1062-8 Minaric-Missoni, 2015, Cyberlindnera fabianii in the neonatal and pediatric intensive care unit: case reports, J. Med. Microbiol. Case Rep., 2, 1 Baghdadi, 2015, First Report of ventriculoperitoneal shunt Infection due to Cyberlindnera fabianii, Case Rep. Infect. Dis. Jindal, 2015, Cyberlindnera (Pichia) fabianii infection in a neutropenic child: importance of molecular identification, J. Med. Microbiol. Case Rep., 2, 1 Grenouillet, 2010, Pichia fabianii fungemia in a neonate, Pediatr. Infect. Dis. J., 29, 191, 10.1097/INF.0b013e3181c4f7d9 Bhally, 2006, Infection in a neonate caused by Pichia fabianii: importance of molecular identification, Med. Mycol., 44, 185, 10.1080/13693780500160793 Yun, 2013, Catheter-related bloodstream infection by Lindnera fabianii in a neutropenic patient, J. Med. Microbiol., 62, 922, 10.1099/jmm.0.048306-0 Valenza, 2006, Identification of Candida fabianii as a cause of lethal septicemia, Mycoses, 49, 331, 10.1111/j.1439-0507.2006.01240.x Wu, 2013, Pichia fabianii blood infection in a premature infant in China: case report, BMC Res. Notes, 6, 1 Hamal, 2008, A case of endocarditis caused by the yeast Pichia fabianii with biofilm production and developed in vitro resistance to azoles in the course of antifungal treatment, Med. Mycol., 46, 601, 10.1080/13693780802078180 Gabriel, 2012, Lindnera (Pichia) fabianii blood infection after mesenteric ischemia, Med. Mycol., 50, 310, 10.3109/13693786.2011.587455 Lee, 2015, Successful treatment of fungemia caused by Cyberlindnera fabianii with anidulafungin: a case report, Ann. Clin. Microbiol., 18, 94, 10.5145/ACM.2015.18.3.94 Fernández-Ruiz, 2017, Fungemia due to rare opportunistic yeasts: data from a population-based surveillance in Spain, Med. Mycol., 55, 125, 10.1093/mmy/myw055 Cooper, 2010, The effect of rituximab on humoral and cell mediated immunity and infection in the treatment of autoimmune diseases, Br. J. Haematol., 149, 3, 10.1111/j.1365-2141.2010.08076.x van Oers, 2006, Rituximab maintenance improves clinical outcome of relapsed/resistant follicular non-Hodgkin lymphoma in patients both with and without rituximab during induction: results of a prospective randomized phase 3 intergroup trial, Blood, 108, 3295, 10.1182/blood-2006-05-021113 Rafailidis, 2007, Infectious complications of monoclonal antibodies used in cancer therapy: a systematic review of the evidence from randomized controlled trials, Cancer, 109, 2182, 10.1002/cncr.22666 2012 Svobodova, 2016, High frequency of Candida fabianii among clinical isolates biochemically identified as Candida pelliculosa and Candida utilis, Mycoses, 59, 241, 10.1111/myc.12454